11/22/2024
4:33 PM | ARCH Venture Fund XII, L.P. (Filed by)
Neumora Therapeutics (Subject)
| Form SC 13D/A | |
11/12/2024
6:17 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2024
5:25 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:01 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:26 PM | Fust Matthew K (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:10 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2024
3:30 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/09/2024
3:10 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/01/2024
4:22 PM | Neumora Therapeutics (Filer)
| Form S-3ASR | |
09/19/2024
3:35 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:37 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:22 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:18 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/27/2024
4:58 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
5:17 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
8:48 AM | Neumora Therapeutics (Subject)
Pinto Joshua (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/06/2024
6:15 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:15 PM | FMR LLC (Filed by)
Neumora Therapeutics (Subject)
| Form SCHEDULE 13G | |
07/08/2024
12:07 PM | FMR LLC (Filed by)
Neumora Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/28/2024
8:00 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:18 PM | Ho Maykin (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:15 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/24/2024
4:00 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
5:46 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:34 PM | Neumora Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
6:08 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:20 PM | Aurora Daljit Singh (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:21 PM | Neumora Therapeutics (Issuer)
Pinto Joshua (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:13 PM | Lenz Robert A. (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:14 PM | Milligan Michael Lee (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:15 PM | Gosebruch Henry O (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:32 AM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
6:52 PM | Burow Kristina (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
6:52 PM | ARCH Venture Fund VII, L.P. (Reporting)
ARCH Venture Fund VIII Overage, L.P. (Reporting)
ARCH Venture Fund X Overage, L.P. (Reporting)
ARCH Venture Fund X, L.P. (Reporting)
ARCH Venture Partners VII, L.P. (Reporting)
ARCH Venture Partners VII, LLC (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
ARCH Venture Partners X Overage, L.P. (Reporting)
ARCH Venture Partners X, L.P. (Reporting)
ARCH Venture Partners X, LLC (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
6:53 PM | ARCH Venture Fund XII, L.P. (Reporting)
ARCH Venture Partners XII, L.P. (Reporting)
ARCH Venture Partners XII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
GILLIS STEVEN (Reporting)
NELSEN ROBERT (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
5:15 PM | Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/12/2023
5:16 PM | Duncan Jason (Reporting)
Neumora Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
3:21 PM | Neumora Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
